Page last updated: 2024-10-25

cilostazol and Heart Septal Defects, Ventricular

cilostazol has been researched along with Heart Septal Defects, Ventricular in 1 studies

Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Umazume, T1
Funabashi, N1
Inoue, T1
Nishi, T1
Shimizu, T1
Jo, K1
Ishikawa, T1
Nakamura, Y1
Miyazaki, A1
Kobayashi, Y1

Other Studies

1 other study available for cilostazol and Heart Septal Defects, Ventricular

ArticleYear
Adverse effects of cilostazol on left ventricular function in a patient with a sigmoid shaped interventricular septum.
    International journal of cardiology, 2013, May-25, Volume: 165, Issue:3

    Topics: Cilostazol; Female; Heart Septal Defects, Ventricular; Humans; Middle Aged; Phosphodiesterase 3 Inhi

2013